Court Affirms Noninfringement Of Hypertension Drug
An appellate court has denied Schwarz Pharma AG's request to reverse a noninfringement ruling for a patent covering hypertension drug Univasc, ruling that asserted claims were abandoned during the patent application...To view the full article, register now.
Already a subscriber? Click here to view full article